NR AEPQ
AU Glatzel,M.; Rogivue,C.; Ghani,A.C.; Streffer,J.R.; Amsler,L.; Aguzzi,A.
TI Incidence of Creutzfeldt-Jakob disease in Switzerland
QU Lancet 2002 Jul 13; 360(9327): 139-41
PT journal article
AB The incidence of Creutzfeldt-Jakob disease (CJD) in Switzerland increased two-fold in 2001, and figures from the first quarter of 2002 indicate that it continues to rise. Neither age at onset nor duration of disease were different from previous years. Genetic analysis of the 27 reported cases revealed only one disease-associated mutation in the prion gene. None of the recognised risk factors for acquired CJD were reported on the official notification forms. Glycotype profiling, histopathology, and immunohistochemistry indicate that none of the cases fulfilled the definition of variant CJD, which is thought to be caused by bovine prions. Several scenarios could account for the increase in CJD, including improved reporting, iatrogenic transmission, and transmission of a prion zoonosis.
MH Aged; Creutzfeldt-Jakob Syndrome/*epidemiology/genetics/pathology; Female; Human; Incidence; Male; Middle Age; Support, Non-U.S. Gov't; Switzerland/epidemiology
AD Markus Glatzel, Adriano Aguzzi (adriano@pathol.unizh.ch), Institute of Neuropathology and National Reference Center for Prion Diseases, Schmelzbergstrasse 12, CH-8091 Zürich, Switzerland; Colette Rogivue, Lorenz Amsler, Federal Office of Public Health, Division of Epidemiology and Infectious Diseases, Bern, Switzerland; Azra C. Ghani, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, UK; Johannes R Streffer, Division of Psychiatry Research, University of Zürich, Zürich, Switzerland
SP englisch
PO England
OR Prion-Krankheiten G